Public filings / PTGX on Yahoo Finance (opens in a new tab)
PTGX: who owns it, insider trades, analyst moves
Protagonist Therapeutics Inc
A summary of public filings about Protagonist Therapeutics Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · dated snapshot
Reported holdings for PTGX
5 rows in loaded coverage. Historical filing values, not current holdings or prices. Related managers may overlap; mappings and share comparisons remain unvalidated. Last successful refresh: 2026-11-11 20:50 ET.
| Reporting manager | Holdings as of | Reported value | Reported-universe weight |
|---|---|---|---|
| Duquesne Family Office | 2026-06-30 | $25,607,000 | 0.59% |
| Farallon Capital | 2026-06-30 | $778,248,897 | 4.56% |
| Perceptive Advisors | 2026-06-30 | $120,358,728 | 1.87% |
| Polen Capital | 2026-06-30 | $2,776,560 | 0.02% |
| RTW Investments | 2026-06-30 | $620,398,832 | 5.30% |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.
